ES459256A1 - Un metodo de preparacion de 3-(3-carboxi-4-hidroxifenil)-4,5-dihidro-2-fenilbenz(e)indol. - Google Patents
Un metodo de preparacion de 3-(3-carboxi-4-hidroxifenil)-4,5-dihidro-2-fenilbenz(e)indol.Info
- Publication number
- ES459256A1 ES459256A1 ES459256A ES459256A ES459256A1 ES 459256 A1 ES459256 A1 ES 459256A1 ES 459256 A ES459256 A ES 459256A ES 459256 A ES459256 A ES 459256A ES 459256 A1 ES459256 A1 ES 459256A1
- Authority
- ES
- Spain
- Prior art keywords
- phenylbenz
- indole
- hydroxyphenyl
- dihydro
- carboxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- HAWWPSYXSLJRBO-UHFFFAOYSA-N fendosal Chemical compound C1=C(O)C(C(=O)O)=CC(N2C(=CC=3C4=CC=CC=C4CCC=32)C=2C=CC=CC=2)=C1 HAWWPSYXSLJRBO-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000001613 neoplastic effect Effects 0.000 abstract 2
- 210000004881 tumor cell Anatomy 0.000 abstract 2
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 206010061309 Neoplasm progression Diseases 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 208000037841 lung tumor Diseases 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 230000001394 metastastic effect Effects 0.000 abstract 1
- 206010061289 metastatic neoplasm Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000005751 tumor progression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/692,331 US4066659A (en) | 1976-06-03 | 1976-06-03 | Method of preparation of 3-(3-carboxy-4-hydroxyphenyl)-4,5-dihydro-2-phenylbenz (e) indole and valuable intermediates related thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES459256A1 true ES459256A1 (es) | 1978-03-01 |
Family
ID=24780138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES459256A Expired ES459256A1 (es) | 1976-06-03 | 1977-05-28 | Un metodo de preparacion de 3-(3-carboxi-4-hidroxifenil)-4,5-dihidro-2-fenilbenz(e)indol. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4066659A (OSRAM) |
| JP (1) | JPS5325556A (OSRAM) |
| AT (1) | AT353786B (OSRAM) |
| BE (1) | BE855406A (OSRAM) |
| CA (1) | CA1105936A (OSRAM) |
| CH (1) | CH629774A5 (OSRAM) |
| DE (1) | DE2724601A1 (OSRAM) |
| DK (1) | DK145296C (OSRAM) |
| ES (1) | ES459256A1 (OSRAM) |
| FI (1) | FI65059C (OSRAM) |
| HU (1) | HU176801B (OSRAM) |
| IT (1) | IT1076781B (OSRAM) |
| NL (1) | NL7705807A (OSRAM) |
| SE (1) | SE425391B (OSRAM) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1356431A (en) * | 1971-06-03 | 1974-06-12 | Wyeth John & Brother Ltd | Substituted benz-g-indoles |
| US3931407A (en) * | 1973-03-01 | 1976-01-06 | American Hoechst Corporation | Method of treatment with and compositions containing condensed pyrroles bearing an N-phenyl substituent |
-
1976
- 1976-06-03 US US05/692,331 patent/US4066659A/en not_active Expired - Lifetime
-
1977
- 1977-05-26 NL NL7705807A patent/NL7705807A/xx not_active Application Discontinuation
- 1977-05-28 ES ES459256A patent/ES459256A1/es not_active Expired
- 1977-05-31 CH CH664677A patent/CH629774A5/de not_active IP Right Cessation
- 1977-06-01 DE DE19772724601 patent/DE2724601A1/de active Granted
- 1977-06-01 IT IT24269/77A patent/IT1076781B/it active
- 1977-06-01 FI FI771747A patent/FI65059C/fi not_active IP Right Cessation
- 1977-06-02 HU HU77HO1992A patent/HU176801B/hu not_active IP Right Cessation
- 1977-06-02 AT AT392877A patent/AT353786B/de not_active IP Right Cessation
- 1977-06-02 DK DK243677A patent/DK145296C/da active
- 1977-06-02 CA CA279,689A patent/CA1105936A/en not_active Expired
- 1977-06-03 BE BE178212A patent/BE855406A/xx not_active IP Right Cessation
- 1977-06-03 JP JP6568277A patent/JPS5325556A/ja active Granted
- 1977-06-03 SE SE7706526A patent/SE425391B/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5325556A (en) | 1978-03-09 |
| HU176801B (en) | 1981-05-28 |
| SE7706526L (sv) | 1977-12-04 |
| SE425391B (sv) | 1982-09-27 |
| FI65059C (fi) | 1984-03-12 |
| AT353786B (de) | 1979-12-10 |
| DK243677A (da) | 1977-12-04 |
| NL7705807A (nl) | 1977-12-06 |
| CA1105936A (en) | 1981-07-28 |
| DK145296C (da) | 1983-03-14 |
| DK145296B (da) | 1982-10-25 |
| CH629774A5 (de) | 1982-05-14 |
| US4066659A (en) | 1978-01-03 |
| IT1076781B (it) | 1985-04-27 |
| DE2724601A1 (de) | 1977-12-22 |
| JPS6120546B2 (OSRAM) | 1986-05-22 |
| FI65059B (fi) | 1983-11-30 |
| DE2724601C2 (OSRAM) | 1988-03-03 |
| FI771747A7 (OSRAM) | 1977-12-04 |
| BE855406A (fr) | 1977-12-05 |
| ATA392877A (de) | 1979-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3033478T3 (en) | Compositions for the diagnosis, prevention, and treatment of tumor progression | |
| Valagussa et al. | Second malignancies in Hodgkin's disease: a complication of certain forms of treatment. | |
| ES8207119A1 (es) | Procedimiento para preparar complejos de platino (iv)-diami-na. | |
| NZ512247A (en) | Compositions and methods for therapy and diagnosis of ovarian cancer | |
| DE3689363D1 (de) | Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren. | |
| DE69631975D1 (de) | Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie | |
| DE69121903D1 (de) | Methoden und zusammensetzungen zur unterdrückung der zelltransformation durch neu | |
| EP0920312A4 (en) | APOPTOSIC INDUCIOUS ADAMANTYL DERIVATIVES AND THE USE THEREOF AS ANTI-DRIVING AGENTS | |
| ES2134294T3 (es) | Reactividad inmune para oncogenes expresados activos para la diagnosis y el tratamiento de tumores malignos. | |
| WO2000055629A3 (en) | Methods of diagnosing and treating breast cancer | |
| NO924025D0 (no) | Antistoffkonjugater for behandling av neoplastisk sykdom | |
| GB1446536A (en) | Pharmaceutically active compositions | |
| JP2714402B2 (ja) | 癌転移抑制剤 | |
| SE7706526L (sv) | Forfarande for framstellnilng av 3-(3-karboxi-4-hydroxifenyl)-4,5-dihydro-2-fenylbens/e/indol och dermed beslektade verdefulla mellanforeningar | |
| DE69942637D1 (de) | Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs | |
| Yamashita et al. | Efficacy of loco-regional lymphnodes irradiation after mastectomy for breast cancer with biopsy proven parasternal lymphnodes metastases-a randomized study | |
| WO1991019725A3 (en) | Heterocyclic anthracyclione and anthracycline analogs | |
| ATE397673T1 (de) | Verstärktes krebs-gen wip1 | |
| Neustaedter | Incidence of metastases to the nervous system | |
| ES8304582A1 (es) | Procedimiento para preparar compuestos de estano. | |
| MX9100290A (es) | Compuestos de antraceno utiles farmaceuticamente. | |
| WO1992015601A3 (en) | Heteroanthracycline antitumor analogs | |
| Suralkar et al. | Evaluation of hemoglobin level among various cancer patients-our institute experience | |
| Voogd et al. | Are risk factors for local and distant recurrence following breast-conserving therapy for early breast cancer similar to those following mastectomy? | |
| JPS5651414A (en) | Antibiotic substance neplanocin preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19971103 |